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Abstract
Introduction
Gestational diabetes mellitus (GDM) is associated with a 7-fold
increased lifetime risk for developing type 2 diabetes mellitus.
Early diagnosis of type 2 diabetes is crucial for preventing com-
plications. Despite recommendations for type 2 diabetes screening
every 1 to 3 years for women with previous diagnoses of GDM
and all women aged 45 years or older, screening prevalence is un-
known. We sought to assess Ohio primary health care providers’
practices and attitudes regarding assessing GDM history and risk
for progression to type 2 diabetes.
Methods
During 2010, we mailed surveys to 1,400 randomly selected Ohio
family physicians and internal medicine physicians; we conducted
analyses during 2011–2013. Overall responses were weighted to
adjust for stratified sampling. Chi-square tests compared categor-
ical variables.
Results
Overall response rate was 34% (380 eligible responses). Among
all respondents, 57% reported that all new female patients in their
practices are routinely asked about GDM history; 62% reported
screening women aged 45 years or younger with prior GDM every
1 to 3 years for glucose intolerance; and 42% reported that screen-
ing for type 2 diabetes among women with prior GDM is a high or
very high priority in their practice.
Conclusion
Because knowing a patient’s GDM history is the critical first step
in the prevention of progression to type 2 diabetes for women who
had GDM, suboptimal screening for both GDM history and sub-
sequent glucose abnormalities demonstrates missed opportunities
for identifying and counseling women with increased risk for type
2 diabetes.
Introduction
Gestational diabetes mellitus (GDM) is glucose intolerance that
initiates or is first diagnosed during pregnancy, excluding overt
diabetes, and affects from 2% to 10% of all pregnant women an-
nually in the United States (1,2). Approximately one third of wo-
men with GDM will be identified as having diabetes or glucose in-
tolerance at their 6-week postpartum visit (3–5). Women with dia-
gnosed GDM are at as much as an 84% increased risk for GDM
during subsequent pregnancies (6), and the risk for developing
type 2 diabetes mellitus during their lifetime is approximately 7-
fold greater than that for women with normoglycemic pregnancies
(7). Prior analyses suggest that cumulative incidence of type 2 dia-
betes ranges from 20% to 60% within 10 years of GDM diagnosis,
plateauing thereafter (8,9). Without appropriate screening, type 2
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diabetes often remains undiagnosed as a result of insidious and
asymptomatic clinical progression until onset of secondary com-
plications, including hypertension, heart disease, stroke, retino-
pathy, and renal failure. Furthermore, uncontrolled type 2 dia-
betes complicates subsequent pregnancies and is associated with
birth defects and birth-related illnesses in the child (10).
The American Diabetes Association (ADA) recommends that wo-
men with prior GDM be screened for type 2 diabetes at 6 to 12
weeks postpartum and at least every 3 years thereafter by testing
fasting plasma glucose, oral glucose tolerance, or hemoglobin A1c
(2). The American College of Obstetricians and Gynecologists
(ACOG) recommends postpartum screening for women who had
GDM, and refers to ADA recommendation for subsequent screen-
ing (11).
In the United States, prevalence of postpartum screening is repor-
ted to be suboptimal for women with prior GDM (12–14). Wo-
men receive preventive medical services from various practition-
ers, and most prior work documenting screening has focused on
care provided by obstetrician/gynecologists (OB/GYNs) and mid-
wives. In Ohio, 70% of OB/GYNs and 50% of midwives reported
almost always screening for type 2 diabetes mellitus during the
postpartum visit (15,16). In 2011, Blatt et al analyzed data from a
laboratory database and found that only 19% of 23,299 women
with GDM-affected pregnancies were tested for diabetes within 6
months after delivery (17). Follow-up screening may also be sub-
optimal; one study reported that during the 5 years after the post-
partum period,  41% of  women with  prior  GDM had not  been
tested for diabetes by an OB/GYN, family practitioner, or internal
medicine physician (18). Few studies have focused exclusively on
general health practitioners; therefore, we surveyed Ohio primary
health care providers to understand their practices and attitudes re-
lated to ascertaining GDM history and screening for subsequent
type 2 diabetes as part of a public health effort to improve type 2
diabetes screening rates for women with a GDM history.
Methods
We developed a questionnaire with 25 questions related to clinical
specialization; patient demographics; and knowledge, attitudes,
and practices regarding GDM, screening for GDM history, and
subsequent screening for type 2 diabetes; other findings from this
survey were published previously (15,16,19). After pilot-testing
the questionnaire for clarity with 4 family physicians, we used
data from the Ohio eLicense Center to randomly sample 700 of
2,253  physicians  licensed  in  Ohio  with  “family  medicine”  or
“family practice” self-reported as specialties and 700 of 4,726 with
“internal medicine” or “general practice” reported (20). We mailed
paper questionnaires up to 2 times during 2010, preceded by a
postcard announcement and interposed by a postcard reminder,
with an option to respond online. Nonrespondents were sent a fi-
nal request by e-mail. We subsequently deemed respondents in-
eligible if they were not treating female patients, worked primar-
ily in a nursing home or long-term care facility, did not routinely
deliver  primary  care,  or  if  they  were  hospitalists,  retired,  or
primarily practicing outside Ohio, as indicated by notes on re-
turned survey reminders, direct communication from respondents,
or survey responses. Respondents were also deemed ineligible if
survey responses indicated that questions regarding screening for
glucose intolerance do not apply to their practice.
Data analysis
Response options to  attitude questions were “strongly agree,”
“somewhat agree,” “somewhat disagree,” “strongly disagree,” and
“unsure”; responses of “somewhat disagree” were grouped with
“strongly disagree.” Response options to the question about prior-
ity  level  for  screening  for  type  2  diabetes  were  “very  high,”
“high,” “moderate,” “low,” and “very low”; responses of high
were  grouped with  “very  high,”  and responses  of  “low” were
grouped with “very low.” All choices were mutually exclusive.
We used Microsoft Excel 2010 (Microsoft Corp) and SAS 9.2,
(SAS Institute, Inc) for data analysis,  including Pearson’s chi-
square tests to compare contingency tables of categorical vari-
ables, 2-proportion z-tests for proportions, and 2-sample Student’s
t tests for continuous variables. We set significance at α = .05. Be-
cause this survey design relied on independently sampled special-
ties, overall responses were weighted to adjust for sampling rates
among specialties, and first-order Rao-Scott chi-square tests were
used for comparisons of weighted responses. Missing data were
excluded from response percentages;  variance estimations  for
overall weighted percentages account for missing responses. Data
were analyzed during 2011–2013.
Among 700 selected primary care physicians, 115 were deemed
ineligible because they indicated that they do not treat female pa-
tients, do not routinely deliver primary care, are retired, primarily
practice outside Ohio, work primarily in a nursing home or long-
term care facility, or reported that questions about screening for
glucose intolerance do not apply to their practice. Among the re-
maining 585 surveyed who were designated as eligible, 230 (39%)
returned completed surveys. Among 700 surveyed internal medi-
cine or general practice physicians, 170 were excluded because of
ineligibility; 530 were eligible, and 150 (28%) of those returned
completed surveys. Overall response rate was 34% (380 eligible
respondents) (Figure). Of those 380 respondents, 66% were men,
74% were primarily in a private practice, and 95% reported that
they do not provide prenatal care (Table 1).
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Figure. Stratified random sampling of primary health care providers surveyed
regarding  attitudes  and  practices  about  screening  women  with  prior
gestational diabetes for type 2 diabetes mellitus — Ohio, 2010.
 
The Centers for Disease Control and Prevention determined that
the survey and analytic activities constituted public health prac-
tice and was exempted from IRB review.
Results
Screening practices and attitudes of respondents
Of all respondents, 57% reported that all new female patients in
their practice are asked if they have a history of GDM; similar pro-
portions of family physicians and internal medicine physicians re-
ported routinely asking about GDM history (57% vs 58%, respect-
ively;  P  =  .85).  Sixty-two percent  of  all  respondents  reported
screening every 1 to 3 years for glucose intolerance among non-
pregnant women aged 45 years or younger with a history of GDM
(Table 1). Sixty-four percent of respondents strongly agreed that
“GDM has long-term implications for a woman’s health”; 65%
strongly agreed that “It is part of my job to help women with a his-
tory of GDM to improve their diet and exercise regularly”; 70%
strongly agreed that “It is important for me to increase patient
knowledge of future risk for type 2 diabetes among patients with a
history of GDM”; and 71% strongly agreed that “There is a need
for periodic screening for type 2 diabetes among women with a
history of  GDM” (Table  2).  Among respondents,  42% ranked
screening for type 2 diabetes among nonpregnant women with pri-
or GDM as a high or very high priority (Table 2). Responses to
these questions did not vary significantly by respondent’s sex, the
demographic population served by the respondent (urban, suburb-
an, or rural), or the percentage of patients with care paid by Medi-
caid (P > .05 for each, data not shown).
Clinician attitudes are associated with screening women with pri-
or GDM for type 2 diabetes (Table 2). Respondents whose prac-
tices screened patients for GDM history strongly agreed more fre-
quently than did respondents who do not routinely ascertain prior
GDM diagnoses with the following: that a part of their job is to
help women with prior GDM improve their diet and exercise (75%
vs 53%; P < .001); that increasing patient knowledge of future risk
for type 2 diabetes among patients with GDM history is important
(77% vs 60%, respectively, P = .002); and that a need exists for
periodic screening for type 2 diabetes among women with a his-
tory of GDM (77% vs 61%, respectively; P = .002). Among the re-
spondents who ask all new female patients about GDM history,
59% ranked screening nonpregnant women with a history of GDM
for type 2 diabetes as a high or very high priority, compared with
24% of respondents who do not routinely ascertain prior GDM
diagnoses (P < .001).
Although 85% of all respondents reported counseling women with
histories of GDM about physical activity, fewer (17%) referred
these women to resources for increasing physical activity; counsel-
ing and referrals for nutrition were similar (Table 3). Comparing
physicians whose practices  screen all  new female patients  for
GDM history with those who do not, 23% versus 10% (P = .003)
refer them to community resources to increase physical activity,
and 38% versus 14% (P < .001) refer these women to nutrition
counseling resources, respectively.
Discussion
The identification of women with prior GDM, and subsequent
lifelong screening for glucose intolerance, is a critical step in pre-
venting type 2 diabetes or identifying the disease early. Screening
is particularly important because many women with prior GDM
lack additional risk factors (such as obesity) and would otherwise
not be screened on the basis of age alone. This study sought to
characterize the practices and attitudes of primary care physicians
regarding long-term screening for type 2 diabetes among women
with prior GDM to aid in the development of public health inter-
ventions to increase screening rates by primary care physicians.
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Rates for  screening were suboptimal,  with approximately half
(57%) of respondents indicating that all new female patients in
their practices are screened for a history of GDM, and fewer than
two-thirds (62%) reporting that, every 3 years, they screen all wo-
men aged 45 years or younger with prior GDM for glucose intoler-
ance. Similarly, Stuebe et al found that 44% of surveyed primary
care providers reported asking women of reproductive age about
GDM history during at least half of office visits (21). These low
rates reflect substantial missed opportunities, not just for early
identification of type 2 diabetes, but also for ensuring healthy fu-
ture pregnancies,  because women with GDM during their first
pregnancy have a nearly tenfold increased risk for GDM during
their second pregnancy (22). Recurrent GDM increases the risk for
adverse newborn outcomes beyond those observed during an ini-
tial  GDM-complicated pregnancy (23).  Early ascertainment of
GDM history is therefore an important first step in providing pre-
ventive care for women between pregnancies (interconception
care).
One limitation of this study is that practices and attitudes related to
screening for GDM history and type 2 diabetes might be overes-
timated if health care providers most interested in the topic respon-
ded more frequently to the survey than did providers for whom
GDM and type 2 diabetes are of less interest. Our response rate
was only 34%; however, surveys of primary care physicians are
often completed at a rate of 40% or lower (12,21). Additionally,
some nonrespondents might have been ineligible for the survey,
and if so, the response rate among eligible survey recipients would
have been higher. Furthermore, respondents might have selected
responses they perceived to be more socially desirable. Thus, the
true screening rates may be lower than reported in this survey, and
these data may not be generalizable beyond clinicians practicing in
Ohio.
This study assessed the care provided to women with prior GDM.
Lifestyle modifications aimed at weight loss and physical activity
are effective for decreasing progression to type 2 diabetes (24),
and both the  ADA and ACOG recommend diet,  exercise,  and
weight management counseling for women with high risk of de-
veloping type 2 diabetes (2,11). Accordingly, most respondents re-
ported providing counseling to improve nutrition (79%) or in-
crease physical activity (85%) when they knew a woman had pri-
or GDM. We also found an association between screening and
physician care, with those reporting screening women for prior
GDM more frequently reporting a role in helping women improve
nutrition, increase physical activity, and better understand their
risk for type 2 diabetes and the need for lifelong screening. Al-
though a causal relationship between these attitudes and practices
cannot be inferred from this cross-sectional survey, these findings
are consistent with the Theory of Planned Behavior, which de-
scribes behavioral practices as partially dependent on a person’s
attitudes (25). Attitudes that could contribute to screening prac-
tices include providers’ perceptions of patient care responsibilities.
Primary care physicians and internal medicine physicians indic-
ated that they have a role in caring for women with prior GDM
(19). However, in the United States, nonpregnant women younger
than 50 years of age see OB/GYNs for most preventive visits (26),
and some primary care providers may rely on such specialists for
ascertainment of GDM history, particularly if the clinical relev-
ance of GDM is perceived to primarily concern pregnancy.
Transition to primary care providers after pregnancy introduces
potential for discontinuity of care for women with prior GDM,
particularly since a decreasing proportion of family physicians in
the United States provide obstetric and maternity care (27). Health
information does not always transfer between practices or health
care systems. One study of providers within a single health care
system found that among 772 women with prior GDM, 46% had
the condition documented in the network’s tool used to manage
patient care, and only 22% of primary care respondents’ intake
forms included assessment of GDM history (21). The same study
reported that  55% of surveyed providers cited communication
gaps between primary care providers and obstetrics and gyneco-
logy care providers as a barrier to providing post-GDM follow-up
care, which further underscores the importance of proactive ascer-
tainment of GDM history (21).
Collectively, these results indicate a series of missed opportunities
for preventing the progression to or early identification of type 2
diabetes. Opportunities for improving women’s health and birth
outcomes include periodic blood glucose screening and equipping
patients to make lifestyle changes, but these opportunities begin
with early identification of GDM history. Opportunities to im-
prove  screening  exist  at  multiple  levels,  including  individual
primary care providers (asking patients about GDM), practices/
clinics (including GDM-related questions on intake forms and im-
plementing policies to ensure screening for GDM history and type
2 diabetes), health care networks (improving documentation of
GDM history; health information exchanges), and insurers (im-
proving access to lifestyle interventions and counseling). These
results also highlight a need for public health agencies to identify
and address barriers that hinder comprehensive follow-up for wo-
men with prior GDM. Providers identified a need for increased re-
sources for improving care of women with prior GDM, including
local nutrition specialists, local resources for physical activity, and
patient education materials (19). Additional challenges that hinder
weight-reduction interventions include insurers’ unwillingness to
pay for obesity mitigation programs, physicians’ limited time for
patient education and monitoring, physicians’ skepticism or uncer-
tainty about the effectiveness of diet and exercise counseling, and
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patients’ failure to comply (28). Public health agencies can reduce
progression of GDM to type 2 diabetes by supporting interven-
tions that address these barriers, thereby empowering physicians to
reduce the long-term impact of GDM. Understanding factors that
contribute to low screening rates is critical for public health inter-
ventions aimed at increasing lifelong type 2 diabetes screening
during primary care visits.
Public health leaders can improve patient outcomes by fostering
better integration of primary care, obstetric, maternal and child
health, and chronic disease systems. In Ohio, a collaborative was
formed at the outset of this study to improve lifelong health out-
comes related to GDM. This group is using these findings to cre-
ate patient education and other resources for women and health
care providers to better understand and provide care for GDM and
to improve care through a quality improvement approach. For ex-
ample, a standard letter is being piloted for obstetric providers to
send to primary care providers after a woman is given a diagnosis
of GDM. The consequences of GDM after pregnancy are well-
documented, and the findings of our study reinforce the need for
public health and primary health care to work together to improve
identification and screening of women with prior GDM.
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Tables
Table 1. Characteristics and Diabetes Screening Practices of Surveyed Primary Health Care Providers in Ohio — 2010
Variable Overall %a (95% CI), N = 380
Sex
Male, n (%) 250 (66)
Female, n (%) 130 (34)
Practice location
Federally qualified health center 5 (3–7)
Hospital 12 (9–16)
University 5 (3–8)
Private, ≤2 physicians 34 (29–39)
Private, >2 physicians 40 (35–46)
Other 3 (1–5)
Predominant patient population
Urban 23 (19–28)
Suburban 54 (48–59)
Rural 23 (19–27)
Percentage of patients with care paid by Medicaid
≤25% 56 (51–61)
26%–50% 19 (15–24)
51%–75% 5 (3–8)
>75% 2 (0–4)
Accept Medicaid; do not know percentage of patients on Medicaid 2 (1–4)
Do not accept Medicaid 15 (11–19)
Do you provide prenatal care?
Yes 5 (3–7)
No 95 (93–97)
In my practice, all new female patients are asked if they have a history of gestational diabetes mellitus
Yes 57 (52–63)
No 43 (37–48)
In your practice, how often are nonpregnant women aged ≤45 years, with histories of gestational diabetes mellitus screened for glucose
intolerance?
Every 1–3 years 62 (56–67)
Dependent on risk factors 31 (26–36)
Do not provide screening 8 (5–11)
Abbreviation: CI, confidence interval.
a Stratified random sample survey design; overall percentages weighted to adjust for sampling rates among provider specialties.
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Table 2. Ohio Primary Health Care Providers’ Attitudes by Screening Practices for Gestational Diabetes Mellitus History — 2010
Survey Question
Overall %a (95%
CI), N = 380
Respondents Who Report Asking All New
Female Patients About Prior GDM, % (95%
CI), n = 197
Respondents Who Report Not Asking All New
Female Patients About Prior GDM, % (95%
CI), n = 149 P Valueb
GDM has long-term implications for a woman’s health.
Strongly agree 64 (59–69) 69 (62–75) 56 (48–65)
.12
Somewhat agree 28 (23–33) 24 (18–31) 34 (26–42)
Disagreec 4 (2–6) 5 (1–8) 4 (1–7)
Unsure 4 (2–6) 3 (0–5) 6 (1–10)
It is part of my job to help women with a history of GDM to improve their diet and increase exercise.
Strongly agree 65 (60–70) 75 (68–81) 53 (44–61)
.002
Somewhat agree 7 (22–32) 19 (13–25) 37 (29–45)
Disagreec 6 (3–8) 5 (2–8) 8 (3–13)
Unsure 2 (0–3) 1 (0–3) 3 (0–5)
It is important to me to increase patient knowledge of future risk of type 2 diabetes among patients with a history of GDM.
Strongly agree 70 (65–75) 77 (71–83) 60 (52–68)
.001
Somewhat agree 25 (20–29) 19 (13–25) 32 (24–40)
Disagreec 3 (1–5) 4 (1–7) 4 (0–7)
Unsure 2 (1–3) 0 (0–1) 5 (1–8)
There is a need for periodic screening for type 2 diabetes among women with a history of GDM.
Strongly agree 71 (66–75) 77 (71–83) 61 (53–69)
.001
Somewhat agree 22 (18–26) 17 (12–22) 30 (22–37)
Disagreec 4 (2–6) 4 (1–7) 3 (0–6)
Unsure 3 (2–5) 1 (0–3) 7 (2–11)
To what extent is screening for type 2 diabetes among nonpregnant women with a history of GDM a priority in your practice?
High or very high 42 (37–48) 59 (52–67) 24 (17–31)
<.001Moderate 37 (32–42) 35 (28–42) 38 (30–46)
Low or very low 20 (16–25) 6 (3–9) 38 (30–47)
Abbreviations: CI, confidence interval; GDM, gestational diabetes mellitus.
a Stratified random sample survey design; overall percentages weighted to adjust for sampling rates among provider specialties.
b First-order Rao-Scott χ2 test.
c Includes responses of “somewhat disagree” and “strongly disagree.”
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Table 3. Prevalence of Gestational Diabetes Mellitus-Related Referrals and Counseling Among Primary Health Care Providers, by
Screening for Gestational Diabetes Mellitus History — Ohio, 2010
Survey Question
Overall %a
(95% CI), N =
380
Respondents Who Report Asking
All New Female Patients About
Prior GDM, % (95% CI), n = 197
Respondents Who Report Not
Asking All New Female Patients
About Prior GDM, % (95% CI), n =
149 P Valueb
When I provide care to women with histories of GDM, I ____ (Select all that apply).
Counsel them about nutrition/diet 79 (74–83) 85 (80–90) 77 (70–84) .09
Counsel them to exercise regularly/
increase physical activity
85 (81–89) 87 (82–92) 86 (80–92) .82
Refer them to a diet support group or
other nutrition counseling resources in
the community
27 (22–32) 38 (31–45) 14 (9–20) <.001
Refer them to community resources to
increase activity
17 (13–21) 23 (17–29) 10 (4–15) .003
Abbreviations: CI, confidence interval; GDM, gestational diabetes mellitus.
a Stratified random sample survey design; overall percentages weighted to adjust for sampling rates among provider specialties.
b First-order Rao-Scott χ2 test.
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